Last reviewed · How we verify

LNG-IUS (BAY 86-5028) — Competitive Intelligence Brief

LNG-IUS (BAY 86-5028) (LNG-IUS (BAY 86-5028)) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Intrauterine contraceptive device (IUD). Area: Contraception / Gynecology.

phase 3 Intrauterine contraceptive device (IUD) Progesterone receptor (local uterine effects) Contraception / Gynecology Small molecule Live · refreshed every 30 min

Target snapshot

LNG-IUS (BAY 86-5028) (LNG-IUS (BAY 86-5028)) — Bayer. LNG-IUS is a levonorgestrel-releasing intrauterine system that provides long-acting reversible contraception by releasing a synthetic progestin directly into the uterus.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
LNG-IUS (BAY 86-5028) TARGET LNG-IUS (BAY 86-5028) Bayer phase 3 Intrauterine contraceptive device (IUD) Progesterone receptor (local uterine effects)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Intrauterine contraceptive device (IUD) class)

  1. Bayer · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). LNG-IUS (BAY 86-5028) — Competitive Intelligence Brief. https://druglandscape.com/ci/lng-ius-bay-86-5028. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: